FORM 8-K

Company

Lexaria Bioscience Corp.

Filed

April 20, 2022

Period of Report

April 19, 2022

Accession Number

0001640334-22-000822

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →